Takeda Pharmaceuticals is nearing an agreement to acquire Shire for approximately $60 billion, the Chicago Tribune reports.
Here's what you should know.
1. People with knowledge of the matter said the companies are attempting to reach a tentative agreement on price, with a potential announcement as soon as May 1.
2. In accordance with U.K. takeover rules, Takeda must announce a preliminary agreement by May 2 or it'll have to abandon the bid.
3. Sources told the Tribune the companies are seeking a possible extension.
4. Talks are still progressing and are fluid. The final figure may vary drastically from the rumored $60 billion.